BIOCON:NSE
Biocon Ltd
₹359.65
arrow_downward
-0.72%(-2.60) 1 天
4月30日, GMT+5:30 14:22:57 · INR
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 BIOCON 生成关键数据洞见…
开盘价
₹360.50
最高价
₹361.20
最低价
₹354.25
市值
五八二四.五六亿
平均成交量
三三八.九六万
成交量
一四二.七七万
股息
〇.一四%
季度股息
₹0.12
除息日
2025年7月4日
市盈率
七四.一五
52 周最高价
₹424.95
52 周最低价
₹317.00
每股收益
₹4.85
流通股数
六.〇〇亿
员工人数
二万
新闻报道
来自全网
资料
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Biocon Ltd简介